News
What if we could reprogramme the TME itself? Cutting-edge research suggests that engineered mesenchymal stem cells (MSCs) ...
Ovarian cancer remains the leading cause of death among cancers affecting the female reproductive system, largely because ...
NEW YORK, May 15, 2025 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem ...
BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative ...
Medical Device Network on MSN13h
FDA approves Roche’s MET protein expression detecting assay for NSQ-NSCLCThe US Food and Drug Administration (FDA) has granted approval for Roche's VENTANA MET (SP44) RxDx Assay for NSQ-NSCLC.
New entity, ErnexaTX2, reflects progress toward clinical readinessCAMBRIDGE, Mass., May 14, 2025 (GLOBE NEWSWIRE) -- Ernexa ...
News-Medical.Net on MSN14d
Existing therapies may help control chronic muscle inflammation in Duchenne muscular dystrophyA new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help ...
Acquisition of mesenchymal markers during ... Molecular characterization of CTCs and targeted therapies. Signaling pathways represented in CTCs regulating stem cells, proliferation and survival ...
Medical Xpress on MSN15d
Existing treatments may help fight symptoms of severe form of muscular dystrophy, new research suggestsA new study led by researchers at Hospital for Special Surgery (HSS) suggests that currently available therapies may help control chronic muscle inflammation in Duchenne muscular dystrophy (DMD), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback